Appearances

• Topic #4 (Liver)
• Update on Hepatitis C Eradication Including Renal Clearance and Dosing and Important DDI Highlights
• Overview of immunosuppression in liver transplant recipients
• Living Donor Issues: Liver
• Deceased Donor Management and Organ Preservation
• Panel Discussion: Overview of Current Allocation by Organ - How Can We Increase Deceased Donor Utilization?
• Renal Dysfunction in Non-Kidney Organ Transplants: Liver, Heart, Lung
• Management of DSA Across all Organ Transplants
• With All Our Drugs, Why Can’t We Develop Evidence-based, Individualized Immunosuppression
• Controversies in Liver-Kidney (2019)
• Deceased Donor Management and Organ Preservation: Who does it best? Kidney Preservation, Liver Perfusion, Ex Vivo Lung
• Overview of Current Allocation by Organ - How Can We Increase Deceased Donor Utilization?
• Key Clinical Trials in Heart, Lung, and Liver
• Transplant Trivia!
• Case Studies: Navigating Equity and Utility in the Real World - Option 1 (Liver and Kidney)
• Session 6: Option 1: Liver Track - Immunosuppression Monitoring and Endpoints